Previously recorded as Johnson & Johnson Consumer Inc. (to 2024)
614 patents currently held
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
116
Ending by 2030
Dec 2026
Next term end
451
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2031 · High confidence
Also notable
Ends Feb 2033 · High confidence
Also notable
Ends Sep 2032 · Low confidence
Also notable
Ends Mar 2027 · High confidence
Also notable
Ends Feb 2029 · Medium confidence
Also notable
Ends Jan 2037 · Medium confidence
Also notable
Ends Jul 2028 · High confidence
Also notable
Ends Mar 2035 · High confidence
Oral Care Device
US 8,684,956
Cited by 158 later US patents, top 5% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Compositions of Microbiota and Methods Related Thereto
US 9,173,910
Cited by 85 later US patents, top 5% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Light Therapy Bandage System
US 10,022,555
Cited by 29 later US patents, top 10% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
Intelligent Performance-Based Product Recommendation System
US 7,809,601
The most cited patent in this portfolio, cited by 825 later US patents, top 1% of utility patents granted in 2010 in our data. Protection runs to 2027.
Skin Imaging System with Probe
US 8,026,942
Cited by 142 later US patents, top 5% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Method of Providing Oral Care Benefits
US 11,351,103
Cited by 47 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2037.
Adhesive Bandage with Decorated Pad
US D708,751
Cited by 74 later US patents, top 10% of design patents granted in 2014 in our data. Protection runs to 2028.
Radiant Energy Knee Bandage Pad Assembly
US D878,608
Cited by 35 later US patents, top 10% of design patents granted in 2020 in our data. Protection runs to 2035.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 11 to 23, 2026 · next Dec 11
- 11 fees due Jan 4 to 25, 2027 · next Jan 4
- 7 fees due Feb 8 to 25, 2027 · next Feb 8
- 9 fees due Mar 5 to 29, 2027 · next Mar 5
- 16 fees due Apr 6 to 27, 2027 · next Apr 6
- 4 fees due May 3 to 21, 2027 · next May 3
- 7 fees due Jun 3 to 30, 2027 · next Jun 3
- 4 fees due Jul 2 to 28, 2027 · next Jul 2
- 10 fees due Aug 2 to 27, 2027 · next Aug 2
- 9 fees due Sep 5 to 30, 2027 · next Sep 5
- 5 fees due Oct 12 to 30, 2027 · next Oct 12
- 6 fees due Nov 3 to 12, 2027 · next Nov 3
Recent changes
- 5 of the patents on this record were granted since Aug 23, 2026
- 5 terms have ended since Aug 23, 2026
- Nov 17 US 7,562,424 Low-Density, Non-Woven Structures and Methods of Making the Same · term ended
- Nov 9 US 8,025,902 Low-Irritation Compositions and Methods of Making the Same · term ended
- Oct 30 US 7,562,427 Low-Density, Non-Woven Structures and Methods of Making the Same · term ended
- Oct 27 US 8,834,943 Compositions Containing Amines and Use Thereof · term ended
- Sep 30 US 8,846,013 Topical Application of 1-Hydroxyl-3,5-BIS(4'HYDROXYL Styryl)benzene · lapsed on the fee record
What they patent
The largest of its 451 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Oral Care Device | 11 in force | to Jul 2032 |
| Light Therapy Bandage System | 7 in force | to Dec 2035 |
| Adhesive Bandage with Decorated Pad (2018) | 6 in force | to Jan 2040 |
| Compositions of Microbiota and Methods Related Thereto | 6 in force | to Feb 2033 |
| Adhesive Bandage with Decorated Pad (2011) | 6 in force | to Dec 2029 |
| Systems, Methods, and Apparatus for Attaching an Otoscope | 5 in force | to Jul 2044 |
| Package Actuator | 5 in force | to May 2033 |
| Compositions Comprising Paulownia Tomentosa Wood Extracts and Uses Thereof | 5 in force | to Mar 2031 |
| Methods of Reducing Hair Loss and/or Facilitating Hair Growth and/or Regrowth | 5 in force | to Jan 2031 |
| Cleansing Compositions | 4 in force | to Nov 2039 |
| Tamper Evident Carton | 4 in force | to May 2039 |
| Methods of Preparing Non-Alcohol Bioactive Essential Oil Mouth Rinses | 4 in force | to Sep 2030 |
| Radiant Energy Back Bandage Pad Assembly | 3 in force | to May 2039 |
| Label for Packaging for Dosage Form | 3 in force | to Apr 2039 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D672,034 | Sanitary Napkin In force · High confidence | In force | High confidence | |
| US 8,480,833 | Intravaginal Device with Fluid Transport Plates And Methods of Making In force · Medium confidence | In force | Medium confidence | |
| US D673,454 | Container In force · High confidence | In force | High confidence | |
| US 7,879,354 | Rapidly Disintegrating Gelatinous Coated Tablets In force · High confidence | In force | High confidence | |
| US 7,809,601 | Intelligent Performance-Based Product Recommendation System In force · High confidence | In force | High confidence | |
| US 10,588,977 | Preserved Compositions Containing Hyaluronic Acid or a Pharmaceutically-Acceptable Salt Thereof and Related Methods In force · Medium confidence | In force | Medium confidence | |
| US 8,697,152 | Anti-Inflammatory Compositions and Personal Care Compositions Comprising Olive Leaf (OLEA Europea) Extract In force · High confidence | In force | High confidence | |
| US D684,063 | Package In force · High confidence | In force | High confidence | |
| US 8,986,665 | Cationic Polyglyceryl Compositions and Compounds In force · High confidence | In force | High confidence | |
| US 8,211,465 | Immediate Release and Sustained Release Ibuprofen Dosing Regimen In force · High confidence | In force | High confidence |
Also on record, not counted in the 614: 2 patents in force now held by others · 42 patents ended · 132 applications pending · 19 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.